TC Biopharm (Holdings)
Financial ratios & Valuation

Historical Multiples (2019 – 2023)

2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.98-5.37-2.25-1.66-0.13N/A-2.25
Price/Sales ratio
8.8214.8415.450.56N/AN/A15.45
Price/Book Value ratio
-11.91-8.77-1.846.600.28N/A-1.84
Price/Cash Flow ratio
-4.49-8.55-5.48-0.14-0.07N/A-5.48
Price/Free Cash Flow ratio
-3.45-8.46-5.46-0.14-0.07N/A-5.46
Price/Earnings Growth ratio
N/AN/A-0.010.010.00N/A-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%100%N/AN/A100%
Operating Profit Margin
-193.78%-348.05%-368.28%-314.31%N/AN/A-368.28%
Pretax Profit Margin
-201.17%-335.06%-757.25%-78.90%N/AN/A-757.25%
Net Profit Margin
-177.07%-275.83%-686.11%-34.16%N/AN/A-686.11%
Effective Tax Rate
-11.98%-17.67%-9.39%-56.69%15.56%N/A-9.39%
Return on Assets
-59.84%-75.10%-169.2%-11.63%-66.13%N/A-169.2%
Return On Equity
238.95%163.06%81.98%-396.54%-219.97%N/A81.98%
Return on Capital Employed
-106.15%-223.60%58.03%-567.83%-340.56%N/A58.03%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/A
Quick Ratio
1.080.520.180.811.20N/A0.18
Cash ratio
0.240.170.070.520.51N/A0.07
Days of Sales Outstanding
11.47N/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A0.840.050.16N/A0.84
Debt Equity Ratio
N/AN/A-0.411.970.55N/A-0.41
Long-term Debt to Capitalization
N/AN/AN/AN/A0.35N/AN/A
Total Debt to Capitalization
N/AN/A-0.690.660.35N/A-0.69
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/A-0.81-23.40-7.04N/A-0.81
Company Equity Multiplier
-3.99-2.17-0.4834.083.32N/A-0.48
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-1.96-1.73-2.82-3.97N/AN/A-2.82
Free Cash Flow / Operating Cash Flow Ratio
1.301.011.001.011.01N/A1.00
Cash Flow Coverage Ratio
N/AN/A-0.81-23.40-7.04N/A-0.81
Short Term Coverage Ratio
N/AN/A-0.81-23.40N/AN/A-0.81
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A